Sunhawk Vision Biotech, Inc. (TPEX:7759)

Sunhawk Vision Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Mar 26, 2026	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	0.01	0.03	0.01
Net Debt / Equity Ratio	-0.82	-0.65	-0.73
Net Debt / EBITDA Ratio	2.82	1.94	2.00
Net Debt / FCF Ratio	3.11	2.01	2.88
Quick Ratio	22.01	30.28	27.44
Current Ratio	23.31	32.62	28.68
Return on Equity (ROE)	-38.75%	-28.80%	-
Return on Assets (ROA)	-22.86%	-20.08%	-
Return on Capital Employed (ROCE)	-29.00%	-33.50%	-36.20%
Buyback Yield / Dilution	-7.28%	-0.92%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.